| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Mayleben Timothy M is a President &CEO at Esperion Therapeutics, Inc.. Recent SEC Form 4 filings include 12 buys and 0 sells.
Estimated insider holdings value: $388K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2020 | ESPR Esperion Therapeutics, Inc. | President &CEO | Buy | 2,500 | $43.00 | $107,500.00 | +2.3% | |
| Feb 28, 2020 | ESPR Esperion Therapeutics, Inc. | President &CEO | Buy | 5,000 | $49.00 | $245,000.00 | +4.8% | |
| Nov 6, 2019 | ESPR Esperion Therapeutics, Inc. | President &CEO | Buy | 5,000 | $36.98 | $184,900.00 | +6.4% | |
| Sep 6, 2019 | ESPR Esperion Therapeutics, Inc. | President &CEO | Buy | 7,500 | $34.55 | $259,106.60 | +3.4% | |
| Aug 1, 2019 | ESPR Esperion Therapeutics, Inc. | President &CEO | Buy | 5,000 | $39.56 | $197,800.00 | +7.6% | |
| Jun 28, 2019 | ESPR Esperion Therapeutics, Inc. | President &CEO | Buy | 5,000 | $46.00 | $230,000.00 | +8.2% | |
| Mar 29, 2019 | ESPR Esperion Therapeutics, Inc. | President &CEO | Buy | 5,000 | $40.00 | $200,000.00 | +8.9% | |
| Mar 20, 2019 | ESPR Esperion Therapeutics, Inc. | President &CEO | Buy | 5,000 | $43.48 | $217,400.00 | +9.8% | |
| Mar 14, 2019 | ESPR Esperion Therapeutics, Inc. | President &CEO | Buy | 5,000 | $48.73 | $243,650.00 | +10.8% | |
| May 4, 2016 | ESPR Esperion Therapeutics, Inc. | President &CEO | Buy | 7,000 | $14.85 | $103,950.00 | +20.2% |